Purpose of Review: Encephalitis and postinfectious encephalitis represent two important conditions for the neurologist, both in terms of their presentations as neurologic emergencies and their potential to cause death or serious neurologic impairment. This article reviews the major infectious and noninfectious causes of encephalitis and discusses postinfectious encephalitis as an indirect effect of systemic illness. Recent Findings: Encephalitis caused by herpes simplex virus type 1 and West Nile virus are of major importance. In addition, within the past few years we have gained improved understanding of the neurologic syndromes caused by varicellazoster virus, the recognition of enterovirus 71 as a significant human pathogen, and the realization that encephalitis may also occur by autoimmune mechanisms requiring immunosuppressive therapy. We have also learned that postinfectious encephalitis may be recurrent rather than monophasic, and that children and adults initially diagnosed with postinfectious encephalitis may later develop classic multiple sclerosis. Summary: Encephalitis and postinfectious encephalitis present as neurologic emergencies requiring prompt diagnosis and initiation of treatment. Important concerns are to identify infectious conditions requiring antibiotic or antiviral therapy and postinfectious or other autoimmune encephalitides requiring immunosuppression.
INTRODUCTION
In approaching patients with suspected CNS infection, the first task for the neurologist, as discussed in the article ''Acute Bacterial and Viral Meningitis,'' is to determine whether the patient has bacterial meningitis requiring emergent antibiotic therapy. When evidence of focal or diffuse parenchymal involvement is present, however, an important diagnostic consideration becomes whether the patient has encephalitis or a postinfectious illness in which systemic infection has caused an immune response directed against myelin or other antigens. In recent years, a third possibility has been recognized: encephalitis may represent an autoimmune response directed against neuronal membrane antigens or intraneuronal proteins. The clinical and radiologic features of these three entitiesVencephalitis, postinfectious encephalomyelitis, and autoimmune encephalopathyVmay differ significantly, and recognition of these differences facilitates diagnosis. This article reviews the presentation, diagnosis, and treatment of these three important clinical entities.
ENCEPHALITIS
Although encephalitis is usually considered in terms of viral infections, other agents may involve brain parenchyma as well. The most urgent question to ask is whether the patient will require antiviral or antimicrobial therapy. Three viral infections are of primary concern: herpes simplex virus (HSV) encephalitis, CNS involvement by varicella-zoster virus, and West Nile virus encephalitis. Other infectious encephalitides, although important, are less common.
Herpes Simplex Virus Encephalitis
HSV encephalitis (Table 2-1) represents only 10% to 15% of cases of viral encephalitis in the United States. However, it remains the most important of viral encephalitides, because it is both lethal if untreated and the only viral encephalitis for which therapy has been proven effective in clinical trials. HSV is ubiquitous in human populations. Two subtypes of HSV infect humans: HSV type 1 (HSV1) and HSV type 2 (HSV2). HSV1 is most commonly acquired in early childhood. HSV2 is more commonly sexually transmitted and thus usually acquired during adolescence or adulthood. Both agents persist in neurons within sensory ganglia. Limited evidence suggests that HSV1 may also persist within the CNS.
1 HSV1 is responsible for 90% of cases of HSV encephalitis in adults; of these cases roughly two-thirds represent reactivated infection. 2 The pathogenesis of HSV encephalitis is not well understood. Encephalitis has been postulated to follow spread of virus from trigeminal ganglia through sensory fibers to the meninges overlying temporal lobes and orbitofrontal cortex. 3 Alternatively, encephalitis could arise following reactivation of a latent virus within the brain. 1 HSV encephalitis affects men and women equally and may occur at any age. There is no seasonal incidence of infection. Impaired host immunity is not a risk factor for HSV encephalitis, but the infection may progress more gradually in immunocompromised individuals. 4 HSV encephalitis is usually unilateral but may also be bilateral. The virus has a predilection for orbitofrontal cortex and temporal lobes, with many cases also involving the cingulate cortex. The virus is able to infect neurons, glia, and ependyma. Vascular congestion and petechial hemorrhages may be present. Progression of the infection results in extensive, frequently hemorrhagic, destruction of the brain. 5 HSV encephalitis presents with an almost universal triad of headache (in over 90% of cases), fever, and alteration in mental status, at times preceded by symptoms of nonspecific mild illness. Changes in mental status at presentation may range from confusion, frank psychosis, or somnolence to stupor or coma. Temporal lobe involvement may result in seizures characterized by olfactory or gustatory hallucinations, or déjà vu phenomena. 6 Examination may reveal subtle or overt corticospinal tract signs or signs suggesting temporal lobe dysfunction. 6 These may include upper-quadrant visual field defects; aphasia when the dominant hemisphere is involved; and, when the infection is bilateral, loss of ability to store and recall new information. Occasional patients will exhibit papilledema at presentation. Rare patients may present with evidence of injury to other parts of the CNS, including occipital lobes and brainstem, without temporal lobe involvement. 7 Focal or generalized seizures, however, may occur at any point during acute illness or after recovery.
CSF in HSV encephalitis typically contains a lymphocytic pleocytosis of 50 or more cells/2L (median 130 cells/2L). 6 In occasional patients, however, cell count may be normal. 6 Although HSV encephalitis is frequently hemorrhagic, the presence or absence of red blood cells in CSF does not differentiate HSV encephalitis from encephalitis due to other causes. 6 Median CSF protein concentration is 80 mg/dL but may range from normal to over 700 mg/dL; CSF glucose concentration is usually normal. 6 MRI with and without gadolinium administration, the initial diagnostic procedure of choice, will usually demonstrate altered signal and gadolinium enhancement within the temporal lobe and may also show involvement of insula, orbitofrontal cortex, or cingulate gyrus (Figure 2-1) . MRI abnormalities in other regions of the cortex or brainstem without temporal lobe involvement do not exclude HSV encephalitis. 5 CT with contrast and EEG are less sensitive but, used together, may provide diagnostic information when MRI is not available. 8 Specific diagnosis of HSV encephalitis is made by amplification of viral DNA from CSF using PCR methods. Overall diagnostic accuracy of PCR in patients with brain biopsy-proven HSV encephalitis is 98%. 9 In some patients PCR may be negative at presentation because of low copy numbers of DNA in CSF. In these cases, repeat CSF PCR in 4 to 7 days may be positive. 10 Diagnostic yield of PCR falls to 21% in patients after 2 weeks of antiviral treatment. 9 Determination of antibody titers is not of value in the acute diagnosis of HSV encephalitis. However, comparison of serum versus CSF antibodies to detect intrathecal production of antibody may be useful retrospectively and in rare cases may provide diagnostic information when PCR is negative. 11 The advent of acyclovir revolutionized the treatment of HSV encephalitis. This agent inhibits HSV synthesis by competing with deoxyguanosine triphosphate as a substrate for DNA polymerase and causing DNA chain termination. 4 Acyclovir is converted to its pharmacologically active monophosphate form by virally encoded thymidine kinase and thus becomes active only in infected cells. 4 Acyclovir is administered at 10 mg/kg body weight every 8 hours for 3 weeks. Complications of acyclovir therapy are usually mild. The major therapeutic concern is nephrotoxicity due to deposition of drug crystals; this is avoided by both controlling the rate of infusion and keeping the patient hydrated. Despite its use for more than 20 years, only a single case of acyclovirresistant HSV encephalitis has been reported. 12 Prior to the advent of specific antiviral therapy, mortality from HSV encephalitis was greater than 70%, with a high rate of severe neurologic sequelae among survivors. Acyclovir reduced mortality to 28%, and rapid institution of antiviral therapy has reduced 1-year mortality to 14%. 13 Patients who are alert or lethargic when treatment is initiated have excellent likelihood of survival, but mortality in patients treated when semicomatose or comatose may be as high as 25%. 6 Adverse prognostic features include coma, advanced age, delayed initiation of treatment, and evidence of extensive CNS involvement on initial MRI or CT. Approximately 30% of patients will be left with permanent neurologic deficits, 6 which may include focal or generalized seizures, impaired memory, aphasia, motor deficits, and impaired cognition. 13, 14 Nonetheless, patients appearing severely impaired immediately after treatment may have good functional recovery over time 6 (Case 2-1).
Varicella-Zoster Virus
Varicella-zoster virus (VZV) ( Table 2 -1) may invade the CNS during primary infection (chicken pox). 15 VZV persists in sensory ganglia following initial infection, like HSV, and may cause encephalitis during reactivated infection. Prior to the advent of PCR, VZV encephalitis was considered unusual. During the past 15 years, however, neurologic complications of VZV infection have been recognized as occurring much more frequently than previously realized. VZV infection is now known to cause a protean array of syndromes of neurologic injury involving not only the brain and spinal cord, but also cranial and peripheral ganglia and nerves. 15 In one series, VZV was found to be the most common agent identified in viral meningitis and encephalitis (29% of isolates), 15, 16 and studies from France and England have identified the agent in 5% to 15% of encephalitis isolates. 17, 18 VZV is thought to involve the CNS following spread of virus within neurons from reactivation in latently infected trigeminal or other ganglia. In contrast to HSV, VZV infects vascular endothelial cells of large and small cerebral vessels, at times followed by spread of the infection into brain parenchyma. 19 In this process, VZV may involve large or small vessels to produce focal or multifocal ischemic injury or may cause vessel wall necrosis with arterial dissection, aneurysm formation, or hemorrhage within the subarachnoid space or brain parenchyma. 15 The classic presentation is that of herpes zoster ophthalmicus, in which initial superficial zoster is followed days to weeks later by involvement of the carotid or middle cerebral artery with stroke and contralateral hemiparesis. 15 However, VZV vasculitis may occur without preceding cutaneous zoster, herpes zoster ophthalmicus, or oticus and may involve virtually any vascular territory within the brain or spinal cord. VZV vasculitis may be more severe in patients with AIDS or other immunosuppression. 15 CSF usually reveals a mononuclear pleocytosis, at times with red blood cells. Hypoglycorrhachia may be present. 15, 20 VZV encephalitis is diagnosed by detection of VZV IgG in CSF; in some patients anti-VZV IgM can be detected as well. 15 Oligoclonal bands are commonly present and are reactive with VZV proteins. 15 PCR has a lower diagnostic sensitivity, and although it is helpful in confirming the diagnosis, a negative PCR result does not exclude VZV. 15 Treatment of VZV encephalitis is with acyclovir, 10 mg/kg every 8 hours for a minimum of 14 days. Oral prednisone, 1 mg/kg given daily for 5 days, may be used to treat the inflammatory component of the vasculitis; more prolonged treatment is avoided to prevent steroid-induced immunosuppression.
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West Nile Virus West Nile virus (WNV) ( 
Case 2-1
Just before traveling back to her college, a 21-year-old woman reported smelling an unusual, extremely unpleasant odor that was inapparent to everyone else in her family. Upon arriving at college, she went to bed. Her roommate was unable to waken her the next morning, and she was brought to the emergency department. Neurologic examination revealed a deeply somnolent woman who did not respond to voice but would react to pain or to loud noise. The patient was without evidence of meningeal irritation, and optic discs were flat. Neurologic examination revealed a right-sided hyperreflexia and right Babinski sign. MRI showed increased signal in the left temporal lobe, insula, and cingulate gyrus on T2 and fluid-attenuated inversion recovery (FLAIR) images, with enhancement in these areas following gadolinium. CSF contained 41 red blood cells/2L and 327 white blood cells/2L, 87% lymphocytes and 13% polymorphonuclear leukocytes, protein concentration of 271 mg/dL, and glucose concentration of 73 mg/dL. The patient was given acyclovir. PCR analysis, reported 2 days later, was positive for HSV1. Acyclovir was continued for 21 days. Over that period of time the patient regained consciousness but remained significantly cognitively impaired. She left college for 18 months and during that time had very slow improvement in intellectual function. Although psychological testing at the end of that time indicated persistent loss of cognitive abilities, she was able to return to school and resume work in her major field of study. She did well scholastically but found that retention of new information was significantly more difficult for her than had been the case prior to her illness.
Comment. This patient's initial olfactory symptoms are classic for temporal lobe seizures and in patients presenting to the emergency department should raise the question of herpes simplex virus encephalitis and suggest initiation of acyclovir if evidence of inflammation is present on CSF examination. The time course of this patient's recovery, extending over many months, is common in patients after herpes simplex virus encephalitis. ravens). Large ''die-offs'' of corvids have been reported to precede some WNV outbreaks in humans. WNV produces infection predominantly in the summer and early autumn, when mosquitoes are most active. The virus has been identified in all US states except Alaska and Hawaii, and human infections have been reported in almost all of these states. In 2011, 690 cases were reported, of which 474 cases represented neuroinvasive disease with 43 deaths (www.cdc.gov/ ncidod/dvbid/westnile/surv&control CaseCount11_detailed.htm). Only 20% of patients develop symptomatic infection, most commonly West Nile fever, which is typically characterized by malaise, fatigue, anorexia, headache, nausea, vomiting, myalgia, fever, eye pain, and a nonspecific maculopapular rash. West Nile fever usually lasts less than 7 days, although occasional patients may remain symptomatic for as long as 6 weeks. 21 Less than 1% of infected patients develop neuroinvasive disease, which is more common in elderly and transplant patients. Neuroinvasive WNV infection may present as meningitis, which is clinically indistinguishable from other viral meningitides; as encephalitis; or as a poliomyelitis with infection of spinal motor neurons (Case 2-2). West Nile encephalitis usually presents with fever, headache, and altered mental status, stupor, or coma. Signs of parenchymal involvement may include stupor or coma, cerebellar ataxia, or movement disorders, including tremor, myoclonus, and parkinsonian symptoms. 23 The most-feared complication of neuroinvasive WNV infection is a syndrome of acute flaccid paralysis (Case 2-2).
23 Occasional patients may also develop chorioretinitis or vitritis. CSF in neuroinvasive WNV infection typically shows a mild elevation in pressure (less than 250 mm H 2 O), lymphocytic pleocytosis, mild elevation of protein concentration, and a normal blood to CSF ratio of glucose concentration. Cell count is usually 50 cells/2L to 260 cells/2L but may be as high as 2600 cells/2L and may be heavily polymorphonuclear, particularly at presentation. 20, 23 In one series, cell count was normal in 20% of patients. 24 Occasional patients have low sodium levels indicative of the syndrome of inappropriate antidiuretic hormone secretion. MRI is often normal, although occasional patients will have areas of increased signal on T2 and FLAIR imaging in the substantia nigra, basal ganglia, and thalamus. 25 A single, acute CSF specimen positive for WNV-specific IgM antibodies is diagnostic of ongoing WNV infection. 25 PCR is less reliable. Paired sera positive for WNV-specific IgM antibodies (a fourfold or greater rise in titer from the ''acute'' serum, obtained 0 to 7 days after symptom onset, and the ''convalescent'' serum, obtained 14 to 21 days after illness onset) also provide serologic confirmation. Treatment of WNV encephalitis is supportive. Prognosis for recovery after encephalitis is good, although recovery may be extremely prolonged. The likelihood of complete recovery after West Nile flaccid paralysis is poor. 23, 25 Other Arthropod-Borne Encephalitides A variety of other arthropod-borne agents may infect humans and cause neurologic disease (Table 2-1). All but two of these agents are carried by mosquitoes, and rates of infection peak in midsummer through early autumn. The exceptions to this rule are Colorado tick fever and Powassan virus encephalitis, which are most frequent in late spring and early summer. Prior to the occurrence of WNV in the United States, St Louis encephalitis had been the most common arthropod-borne cause of encephalitis, and Eastern equine encephalitis virus the most dangerous. Other, less common agents include viruses of the Eastern equine encephalitis virus (EEEV) is an agent of wading and migratory birds. 26 The virus is found predominantly along the Atlantic seaboard, the Gulf of Mexico coast, and states abutting Lake Michigan (Indiana, Michigan, and Wisconsin). Incidental exposure or spread of the virus into other mosquito species facilitates the spread of the virus into humans or other species. Although the virus does not usually produce severe infection in its natural hosts, it can produce severe epizootic infection in flocks of turkeys or in exotic or game-farm birds, as well as infections in horses. EEEV encephalitis is rare in humans, and reported cases over the past 4 decades have averaged only five cases annually. EEEV infections are less likely to be asymptomatic than are infections with other arthropod-borne 
Case 2-2
During a late-summer weekend, an emergently hospitalized 48-year-old man was diagnosed with Guillain-Barré syndrome due to Epstein-Barr virus (EBV). The patient had been in good health until 10 days prior to admission, when he had a mild systemic illness with fever and myalgias that quickly resolved. On the day of admission, he awoke with bilateral leg weakness that subsequently involved his arms. Lumbar puncture revealed 32 cells/2L, 81% lymphocytes, 11% monocytes, and 8% neutrophils, with a protein concentration of 120 mg/dL, and a glucose concentration of 72 mg/dL. CSF PCR detected EBV DNA. By the time the neurologist saw the patient, he was in respiratory distress, with normal cranial nerves and sensory examination but with flaccid upper and lower extremities. Gadolinium-enhanced MRI showed increased signal in anterior horns at several levels in cervical and thoracic spine. WNV IgM was detected in both serum and CSF, with evidence of intrathecal antibody production. The patient became ventilator dependent, could not be weaned, and died several weeks later after ventilatory support was terminated at the request of the patient and his family.
Comment. Neuroinvasive WNV infection may cause meningitis, encephalitis, or a poliomyelitis with destruction of anterior horn cells. The virus should be a diagnostic consideration in patients presenting with any of these clinical features in summer or early autumn. EBV produces latent infection of B lymphocytes, and EBV DNA can thus be present in CSF in any infection resulting in a lymphocytic pleocytosis and may not signify that EBV is the causative agent.
agents, in particular in individuals at the extremes of life. In individuals between 4 and 55 years of age, the ratio of inapparent EEEV infections to cases of encephalitis is 29:1. In contrast, the ratio in infants is 8:1, and the ratio in individuals over 55 years of age is 16:1.
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EEEV encephalitis is frequently preceded by a prodromal illness, which may include fever, headache, and abdominal pain that may occasionally be severe enough to mimic an acute abdominal emergency. 28 Onset of the encephalitis is frequently abrupt and severe, particularly in children or older adults. Presentation as a meningitis is unusual, and nearly 70% of patients present in stupor or coma. 28 Focal signs of corticospinal or extrapyramidal dysfunction may be present, and the illness may be complicated by focal or generalized seizures. Overall mortality approaches 36%, with 35% of survivors having significant neurologic impairment. 28 
Enteroviral Encephalitis
Enteroviruses are small, unenveloped single-stranded RNA viruses within the family Picornaviridae (Table 2-1). Although over 70 serotypes of enteroviruses have been identified, coxsackievirus A9 and echoviruses E7, E9, E11, E19, and E30 have accounted for 70% of all cultured isolates from CSF. Enteroviruses are disseminated by fecal-oral spread. Enteroviral infections tend to cluster during summer months, when conditions of sanitation tend to be most relaxed, but may also occur throughout the year. Although enteroviruses are most commonly associated with viral meningitis (see preceding article), they may also cause encephalitis and, rarely, paralytic disease. Enterovirus 71 most commonly causes the childhood conditions hand, foot, and mouth disease and herpangina. Hand, foot, and mouth disease is characterized by oral ulcers and a cutaneous rash, whereas lesions in herpangina are confined to the oropharynx. In addition, however, enterovirus 71 may produce more severe disease with involvement of brainstem or, less frequently, of cortex, cerebellum, or spinal ventral roots. 29 CSF findings in enteroviral meningoencephalitis are typically a mild lymphocytic pleocytosis, mild elevation of protein concentration, and normal glucose concentration. 20 During the first 24 to 48 hours of infection, CSF may contain a mixture of polymorphonuclear leukocytes and lymphocytes. 20 MRI studies are usually unremarkable but have shown cerebral or hippocampal lesions in some patients. 30 Enterovirus 71 has been associated with MRI abnormalities in brainstem and, less frequently, cortex or cerebellum; these may be best seen on diffusion-weighted images. 31 Pleconaril, an antiviral drug that binds to a hydrophobic pocket in the major protein of the enterovirus capsid VP1, has been shown to be of modest benefit in cases of enteroviral CNS infections but is not approved for use in the United States.
32,33
Other Viral Agents Mumps virus was formerly a major cause of viral meningoencephalitis but has essentially disappeared as a causative agent of meningoencephalitis in the Western world following introduction of widespread immunization. The mouse arenavirus, lymphocytic choriomeningitis virus, may cause meningitis or encephalitis in individuals exposed to infected mice or hamsters (Table 2-1).
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The infection is rarely fatal, but recovery can be prolonged, and the infection is one of the few viral CNS infections that may cause hypoglycorrhachia. Parvovirus B19, the agent of the childhood condition erythema infectiosum (fifth disease), may cause encephalitis in both children and adults. 35 A number of viruses typically produce infections in immunocompromised patients and do so only infrequently in healthy individuals. Cytomegalovirus is classically associated with encephalitis in neonates but may also cause encephalitis in adults and was a major complication of AIDS prior to the widespread use of highly active antiretroviral therapy. The virus may also cause encephalitis in other groups of immunocompromised patients and occasionally in individuals without underlying disease. 36 Herpesviruses 6 (HHV-6, associated with roseola infantum) and HHV-7 are frequent agents of early childhood infection and in this setting may result in convulsions and, rarely, encephalopathy. 37 HHV-6 has also been associated with encephalitis, often involving limbic structures, in transplant or other immunosuppressed individuals. In one study, HHV-6 was detected in the CSF of 40% of patients with encephalitis of otherwise undetermined cause, suggesting that it is an underappreciated causative agent for viral encephalitis. 38 EBV has been associated with a wide variety of neurologic syndromes, including meningitis, encephalitis, and postinfectious encephalitis. Although the virus is almost certainly responsible for cases of encephalitis, the association of EBV with individual cases is made difficult by the fact that the virus produces latent infection of lymphocytes, so detection of EBV by PCR methods in patients with CSF pleocytosis may or may not indicate that the virus is the causative agent. Treatment of cytomegalovirus encephalitis has been with ganciclovir, with foscarnet used as an alternative agent 33 ( Table 2 Rabies virus is a rare cause of viral encephalitis in Western countries but remains a significant concern in countries where dogs are not routinely vaccinated. In the United States, rabies is most frequently associated with bat bites and less often with bites from raccoons, skunks, and foxes. Treatment of animal bites includes cleaning of the infected wound, injection of rabies immunoglobulin, and immunization with human diploid cell rabies vaccine (www.cdc.gov/rabies/ exposure/ ). Only five individuals are known to have survived rabies. One surviving patient was treated with induced coma using ketamine, midazolam, and phenobarbital. 39, 40 The possibility of rabies should be considered in patients known to have suffered animal bites or to have been exposed to bats, and in patients from underdeveloped countries. It is important to remember that the incubation period of rabies may be up to several years and that the puncture wounds produced by bat bites may be so small as to escape detection. 41 
Encephalitis Caused by Nonviral Agents
A number of treatable bacterial and other organisms may produce brain parenchymal involvement to mimic viral encephalitis (Table 2-1). Meningovascular syphilis may present with subacutely or acutely progressive symptoms, and parenchymal changes that resemble HSV encephalitis may be seen on MRI (Figure 2-2 ).
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Listeria monocytogenes may produce rhombencephalitis or brainstem encephalitis in both immunosuppressed and immunologically healthy individuals. L. monocytogenes may occasionally produce cortical encephalitis resembling HSV encephalitis on MRI. 43 Mycoplasma has most commonly been associated with postinfectious encephalitis (see below) but may also involve the CNS acutely. Rickettsia rickettsii, the agent of Rocky Mountain spotted fever, can produce a cerebral vasculopathy and may do so in the absence of a cutaneous rash. 44 The disease, spread by ticks, occurs in most states but is prevalent along the Mid-Atlantic seaboard. Cases occur throughout the year but are most common between April and September (www. cdc.gov/rmsf/stats/ ). Other rickettsial species, including Rickettsia prowazekii, the agent of epidemic typhus, have also been associated with human infection. 45 Treatment regimens for these infections are shown in Table 2 -2.
Autoimmune Encephalitis
An emerging concern in the diagnosis of patients presenting with encephalitis is the recognition that paraneoplastic and other autoimmune conditions may present as limbic or other encephalitis ( as anti-Hu, anti-Ri, or anti-Ma1 or Ma2, as well as in patients expressing a number of autoantibodies against neural surface antigens, including the NMDA receptor (NMDAR), the !-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR), the metabotropic glutamate receptor subunit mGluR5, components of the voltage-gated potassium channel complex (leucine-rich, glioma inactivated 1, and contactin-associated proteinlike 2), and +-aminobutyric acid B receptors. 46 These conditions differ from acute viral encephalitis in that their onset is usually more gradual and they tend to be progressive over time. The most frequent of these appears to be encephalitis associated with anti-NMDAR antibodies. The presence of these antibodies was initially found in patients with ovarian teratomas. However, in epidemiologic studies by the California Encephalitis Project, anti-NMDAR encephalitis was identified over 4 times more frequently No clear tumor association 960% of patients may have hyponatremia NMDAR = NMDA receptor; AMPAR = !-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor; mGluR5 = metabotropic glutamate receptor 5; GABA(B) = +-aminobutyric acid receptor type B; VGKC = voltage-gated potassium channel; LGi1 = leucine-rich, glioma inactivated 1; CASPR2 = contactin-associated proteinlike 2. a The role of antibodies directed against internal neuronal proteins in disease causation has not been determined.
than HSV1, WNV, or VZV and was the leading cause of identified encephalitis. 46 In this study, 65% of cases occurred in patients aged 18 years or younger. 46 The condition was more common in females and tended to be characterized by seizures, language dysfunction, psychosis, autonomic instability, and EEG abnormalities. 46 CSF usually showed a mild lymphocytic pleocytosis (average 23 cells/2L; range 0 to 252 cells/2L), normal or mildly elevated protein concentration, and normal glucose concentration. MRI showed temporal lobe abnormalities in 48% of patients. 46 Most patients had no teratomas or other neoplasms.
Standardized regimens of treatment for autoimmune encephalitis have not yet been developed. Treatment has relied on corticosteroids, with plasma exchange, IV immunoglobulin (IVIg), and immunosuppressive or immunomodulatory agents, such as cyclophosphamide or rituximab. 47 Patients with antibody response against cell surface antigens have, in general, responded well to treatment. 44 Patients with antibodies directed against intracellular proteins, such as anti-Hu, have tended to be much more resistant to treatment. 47 
POSTINFECTIOUS ENCEPHALITIS
Postinfectious encephalitis was traditionally defined as an acute, monophasic, demyelinating illness that usually occurs within 2 to 4 weeks of viral or other illness and believed to be an immune attack on components of myelin or other related antigens (Case 2-3). Although postinfectious encephalitis has most frequently been associated with viral infections, cases have also been associated with infections due to a wide variety of other agents ( Table 2-4) . 48 The condition is characterized by multifocal perivenous demyelination and bears strong similarity to 
Case 2-3
A 16-year-old boy had been in good health until 2 weeks prior to admission, when he developed a flulike illness characterized by fever, myalgias, and cough. He recovered from the illness without difficulty but on the morning of admission was confused upon awakening and then became unresponsive. General physical examination was normal except for very mild nuchal rigidity. Neurologic examination revealed the patient to be stuporous but able to move all four extremities in response to pain. The patient had brisk reflexes with bilateral Babinski signs. CSF contained 34 white blood cells, protein concentration of 78 mg/dL, and glucose concentration of 65 mg/dL with a simultaneous blood glucose level of 104 mg/dL. MRI revealed multiple irregular areas of increased signal on T2 and FLAIR imaging, with gadolinium enhancement of two of the lesions. All cultures were negative, as were test results for PCR, HSV, VZV, enteroviruses, EBV, and Mycoplasma pneumoniae. CSF and serum serology for WNV was negative, but the patient had elevated antibody titers to M. pneumoniae. The patient was diagnosed with postinfectious encephalomyelitis and treated with a 5-day course of IV methylprednisolone 1000 mg/d, followed by a prednisone taper. He regained consciousness over the next several days and improved steadily, returning to school on a part-time basis after 3 months. When seen in follow-up at 6 months, he was neurologically healthy.
Comment. This patient's course of an acute neurologic illness following a systemic illness is classic for postinfectious encephalitis, as were the changes seen on MRI. Prognosis for complete recovery is excellent in most cases. two other conditions: (1) postvaccinal encephalomyelitis that follows immunization and (2) the experimental autoimmune demyelinating disease, experimental allergic encephalomyelitis. 48, 49 In recent years, postinfectious and postvaccinal encephalomyelitis have been grouped under the common term acute disseminated encephalomyelitis (ADEM). 49, 50 ADEM is not the consequence of a specific infection or immunization but rather a final common pathway of autoimmune CNS injury triggered by many agents or immunogens.
Postinfectious encephalitis is most common in children but can also occur in adults. The condition is rare in older adults. In children, the peak age at onset is 5 to 8 years. The disorder is more common in winter and spring months. A study from San Diego County gave a mean incidence of 0.4 per 100,000 per year among individuals younger than 20 years. Of these patients, 93% reported symptoms of infection within 21 days of the onset of illness and an additional 5% had received immunization within the preceding month. 51 The onset of ADEM may be preceded by fever, malaise, headache, nausea, or vomiting. These prodromal symptoms are followed by the abruptVat times fulminantVonset of illness. Altered mental status, which is almost universal in children, may range from drowsiness to frank coma. Meningeal signs are common. Focal or multifocal neurologic signs may involve brain, spinal cord, or optic nerves and include unilateral or bilateral corticospinal tract signs, hemiplegia, ataxia, cranial nerve palsies, and visual loss. Hemispheric involvement may produce aphasia or parietal lobe findings of sensory loss or neglect. Focal or generalized seizures may occur; these are rare in adults but common in young children, occurring in up to 70% of children younger than 5 years, 80% of whom may develop status epilepticus. 52 In many cases, ADEM is confined to the brain and spinal cord. However, the disorder may simultaneously cause optic neuritis or involve the peripheral nervous system. The simultaneous occurrence of central and peripheral demyelinating events appears to be more common in adults than in children. 53 Postinfectious encephalitis should be considered in the differential diagnosis of any patientVin particular any childV presenting with evidence of acute, inflammatory neurologic illness in the setting of a previous systemic illness. Making the diagnosis, however, should be preceded by ruling out actual CNS infection. The presence of multifocal neurologic signs should raise the level of suspicion of ADEM, as should the presence of signs referable to both the CNS and the peripheral nervous system. CSF typically shows a lymphocytic pleocytosis, although roughly 30% of patients will have a mixed pleocytosis with a neutrophilic predominance. 48 The frequency with which oligoclonal bands are detected is controversial. 48, 54 Traditionally, the presence of oligoclonal bands was considered unusual. However, oligoclonal bands were detected in 20% of patients with ADEM in one study. 55 In another study, oligoclonal bands were reported in 65% of individuals presenting an illness initially diagnosed as ADEM; however, over 50% of these patients were subsequently diagnosed with multiple sclerosis. 54 MRI with gadolinium enhancement is the diagnostic study of choice. T2 and FLAIR images classically show multiple, large, asymmetric, irregularly shaped lesions involving subcortical white matter and the gray-white junction of both cerebral hemispheres (Figure 2-3) . 54 Periventricular white matter may be involved, but lesions confined to the corpus callosum are unusual. 53 Gadolinium enhancement is seen in 30% to 100% of patients and may vary with the stage of the disease. 51 Ring-enhancing lesions may be found but should raise particular concern about brain abscess or other CNS infection. 52 Spinal cord involvement, usually with extensive cord edema and swelling, may occur in children or adults and commonly affects the thoracic cord. 52 Despite their worrisome appearance at presentation, most lesions resolve over time. 53 Randomized controlled trials of different therapeutic agents do not exist for ADEM in children or adults, nor do studies exist comparing one agent with another. 48, 53 Class 3 evidence exists for the use of methylprednisolone, usually used as 1 g per day for 5 days. 56 Plasma exchange (usually five exchanges) or IVIg, given to a total dose of 1 g/kg to 2 g/kg during 3 to 5 days, has also been used, either in combination with methylprednisolone or after methylprednisolone failure. 48 A variety of other immunosuppressive agents, including cyclophosphamide, have been used in individual cases.
The outcome of ADEM is usually favorable. In most studies, 50% to 75% of patients undergo complete recovery over time 52, 54 ; up to 90% of children may undergo essentially complete recovery, although some may have persistent mild neurocognitive deficits. 52, 53 The likelihood of residual deficit may also be greater in patients presenting with optic neuritis. 52 In recent years it has been realized that ADEM may be recurrent. 49 An ongoing diagnostic challenge is the recognition that a subset of patients, perhaps as high as 30%, will later develop multiple sclerosis. 49, 55 Acute Hemorrhagic Leukoencephalitis In occasional patients (2% of a large cohort of children 52 ), postinfectious encephalitis may be much more severe, presenting with fulminant hemorrhagic demyelination and cerebral edema. MRI studies, in addition to findings suggestive of demyelination, hemorrhage, and edema, may show evidence of ischemia on diffusion-weighted images. 57 This disorder has also been termed acute necrotizing hemorrhagic leukoencephalitis or Weston Hurst syndrome. Unlike postinfectious encephalitis, acute necrotizing hemorrhagic leukoencephalitis has a high rate of mortality. In individual reports, however, some patients may survive following aggressive and early treatment using combinations of methylprednisolone, IVIg, plasma exchange, or cyclophosphamide. 53 
APPROACH TO THE PATIENT WITH ENCEPHALITIS OR POSTINFECTIOUS ENCEPHALITIS
The possibility of meningitis or encephalitis should be suspected in any severely ill patient presenting with alteration in consciousness, with or without focal neurologic signs. Signs suggesting temporal lobe involvement should hint at HSV encephalitis but may occasionally be caused by other agents. The possibility of arthropod-borne encephalitis, enterovirus encephalitis, or Rocky Mountain spotted fever should be kept in mind in patients presenting during summer months. In areas of geographic prevalence, a history of tick bite may suggest Rocky Mountain spotted fever. The presence of a generalized skin rash may suggest Rocky Mountain spotted fever or WNV infection. Presentation with abrupt onset of impaired consciousness with multifocal neurologic signs following a systemic infection of almost any sort, especially in childhood, should raise the possibility of postinfectious encephalitis.
At presentation, the overriding clinical concern is that the patient may have acute bacterial meningitis, and patients should be treated with antibiotics until bacterial meningitis has been excluded. HSV encephalitis should be suspectedV and, like bacterial meningitis, treated on suspicionVin any individual presenting with altered consciousness and evidence of inflammatory CSF response, unless some other cause for the condition is identified at presentation. MRI with gadolinium is an essential diagnostic tool in HSV encephalitis; however, it should be kept in mind that neurosyphilis and infections by other agents, including L. monocytogenes, may occasionally mimic MRI findings seen in HSV encephalitis.
The supportive care of patients with encephalitis or postinfectious encephalitis is both complex and demanding. Treatment of seizures is usually straightforward but may occasionally require aggressive therapy. Some patients will develop the syndrome of inappropriate antidiuretic hormone secretion and may require careful attention to electrolyte balance. Cerebral edema may become a major concern. Although dexamethasone has been used for many years to reduce cerebral edema in patients with encephalitis, its efficacy has not been established and is currently being evaluated in patients with HSV encephalitis in a multicenter trial. Decompressive craniectomy has been associated with patient survival in one case of HSV encephalitis with intractable cerebral edema. 58 In severely ill patients, survival may depend heavily on meticulous attention to details of daily care. Because recovery from encephalitis or postinfectious encephalitis may be extremely prolonged, patients may not reach optimal improvement for weeks or months. In such cases, the recovering patient and his or her family may need ongoing counseling over time.
